NMD raises $3M seed round

NMD Pharma (Aarhus, Denmark) raised $3 million in a seed round from Lundbeckfonden Emerge, Novo Seeds and Capnova. NMD is developing small molecules that increase neuromuscular transmission to treat Orphan motor neuron dieases, including myasthenia gravis, amyotrophic lateral sclerosis and spinal muscular atrophy (SMA). ...